SAXENA PARAG - 18 Dec 2024 SCHEDULE 13D/A Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.001 par value (RVPH)

Filing Manager: SAXENA PARAG
Reporting Manager: Parag Saxena
Security: REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.001 par value
Symbol: RVPH
Shares outstanding: 50,555,694 shares
Disclosed Ownership: 6,268,906 shares
Ownership: 12%
Form type: SCHEDULE 13D/A
Filing time: 31 Jan 2025, 21:31:18 UTC
Date of event: 18 Dec 2024
Next filing: 01 Jul 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vedanta Associates-R, LP	4.1%	1,967,768	0	1,967,768	By: Vedanta Partners, LLC, the general partner ("GP") of Vedanta Associates-R, L.P. /s/ Parag Saxena	Parag Saxena/CEO of Vedanta Partners, LLC	0001865703
Vedanta Associates, L.P.	6.9%	3,408,401	0	3,408,401	By: Vedanta Partners, LLC, the GP of Vedanta Associates, L.P. /s/ Parag Saxena	Parag Saxena/CEO of Vedanta Partners, LLC	0001502222
Beta Operators Fund, L.P.	4.4%	2,138,130	0	2,138,130	By: Vedanta Associates, L.P., the GP of Beta Operators Fund, L.P. By: Vedanta Partners, LLC, the GP of Vedanta Associates, L.P. /s/ Parag Saxena	Parag Saxena/CEO of Vedanta Partners, LLC	0001614642
VEDANTA PARTNERS, LLC	11%	5,376,169	0	5,376,169	/s/ Parag Saxena	Parag Saxena/CEO	0001502216
Parag Saxena	12%	6,268,906	892,737	5,376,169	/s/ Parag Saxena	Parag Saxena/Individual	0001015823